CRYOPRECIPITATE PRODUCTION IN RUSSIA: PAST, PRESENT AND FUTURE
https://doi.org/10.35754/0234-5730-2019-64-1-16-20
Abstract
Aim. To determine the dynamics of cryoprecipitate production in Russian blood service institutions in comparison with such institutions in other countries.
Materials and methods. Reports provided by Russian blood service institutions during the 1997–2017 period were analysed, along with European standards for blood collection and transfusion.
Results. Over the 1997–2004 period, the number of cryoprecipitate units issued annually ranged from 263,897 (2000) to 297,890 (2002) units. Over the subsequent 8 years, the number of annually released cryoprecipitate decreased to 23,663 units, having reached a historical minimum in 2012. From 2012 to 2017, the number of annually issued cryoprecipitate units increased by 80.0 %, reaching the amount of 42,589 units. Reasons for such a wavelike dynamics in cryoprecipitate production in Russia have been determined. In addition, directions for expanding the use of this product in the correction of hypofibrinogenemia have been identified.
Conclusion. Cryoprecipitate should be re-introduced into the practice of clinical transfusiology. To this end, national clinical guidelines for cryoprecipitate application should be developed.
Keywords
About the Authors
E. B. Zhiburt
National Medical and Surgical Center named after N.I. Pirogov
Russian Federation
Russian Federation
Evgeny B. Zhiburt , Dr. Sci. (Med.), Prof., Departmental Head, Department of Transfusiology
tel .: +7 (495) 211-79-51; 105203, Moscow, Nizhnya Pervomaiskaya str., 70
I. G. Chemodanov
Blood Сentre
Russian Federation
Russian Federation
Igor G. Chemodanov, Chief Medical Officer
тел.: +7 (3652) 27-87-45; 295017, Simferopol, Kievskaya str., 37/2
E. A. Shestakov
National Medical and Surgical Center named after N.I. Pirogov
Russian Federation
Russian Federation
Evgeny A. Shestakov, Dr. Sci. (Med.), Assoc. Prof., Department of Transfusiology
тел.: +7 (499) 464-46-63; 105203, Moscow, Nizhnya Pervomaiskaya str., 70
References
1. Zhiburt E.B. Blood component therapy. Moscow: Pirogov National Medical Surgical Center, 2017. 62 p. (In Russian).
2. Pool J.G. Cryoprecipitated factor VIII concentrate. Thromb Diath Haemorrh Suppl. 1968; 35: 35–40.
3. Stepanova I.P., Belov E.V., Selivanov E.A., Danilova T.N. Production transfusiology of Russia at the present stage. Transfuziologiya. 2000; 1(1): 6–27 (In Russian).
4. Selivanov E.A., Danilova T.N., Degtereva I.N. Russian blood service in 2001. Transfuziologiya. 2002; 3(4): 7–30 (In Russian).
5. Selivanov E.A., Danilova T.N., Bystrov M.V. Russian blood service in 2003. Transfuziologiya. 2004; 5(4): 7–36 (In Russian).
6. Selivanov E.A., Danilova T.N., Degtereva I.N. Russian blood service in 2005. Transfuziologiya. 2006; 7(3): 4–43 (In Russian).
7. Selivanov E.A., Danilova T.N., Degtereva I.N. Characteristics of the activities of blood institutions of Russia in 2007. Transfuziologiya. 2008; 9(3): 4–27 (In Russian).
8. Selivanov E.A., Danilova T.N., Degtereva I.N. Russian blood service: current state and development prospects. Transfuziologiya. 2010; 11(3): 4–31 (In Russian).
9. Selivanov E.A., Chechetkin A.V., Grigor’yan M.Sh. The current state of blood donation and its components in the Russian Federation. Transfuziologiya. 2012; 12(3): 4–13 (In Russian).
10. Chechetkin A.V., Grigor’yan M.Sh., Makeev A.B. Russian blood service in 2012. Transfuziologiya. 2013; 14(3): 4–15 (In Russian).
11. Chechetkin A.V., Danil’chenko V.V., Grigor’yan M.Sh. The main results of the activities of the blood service of the Russian Federation in 2015. Transfuziologiya. 2016; 17(3): 4–13 (In Russian).
12. Chechetkin A.V., Danil’chenko V.V., Grigor’yan M.Sh., et al. Key performance indicators of the blood service of the Russian Federation in 2017. Transfuziologiya. 2018; 19(3): 4–14 (In Russian).
13. Zhiburt E.B., Gubanova M.N., Gajvoronskaya V.V., et al. The development of the US blood service. Transfuziologiya. 2017; 18(3): 86–91 (In Russian).
14. Guide to the preparation, use and quality assurance of blood components, 19th edn. Council of Europe Publishing, Strasbourg, 2017. 545 p.
15. Guidelines for the blood transfusion services in the United Kingdom. 8th edition, 2013. Available at: http://www.transfusionguidelines.org/red-book/publication-information
16. Zhiburt E.B. Circulation of blood components and products. Remedium. 2004; 11: 56–7 (In Russian).
17. Program treatment of diseases of the blood system: a collection of diagnostic algorithms and protocols for the treatment of diseases of the blood system. Savchenko V.G., ed. Moscow: Praktika, 2006 (In Russian).
18. Postnikova N.S. Legal aspects of the treatment of orphan diseases under the program “Seven Nosologies”. Pravovye voprosy v zdravoohranenii. 2013; 6: 14–25 (In Russian).
19. Order No 363 of 25 November 2012 of the Ministry of Health of the Russian Federation “Approving the Instruction for Use of Blood Components” (In Russian).
20. Order No 183н of 02 April 2013 of the Ministry of Health of the Russian Federation “Approval of the regulations of the clinical use of the donor blood and (or) its components” (In Russian).
21. Decision No. 29 of the Government of the Russian Federation of 26 January 2010 “About approving the technical regulation concerning safety of the blood, blood products, blood substituting solutions and technological means used in transfusion and infusion therapy” (In Russian).
22. Lunde J., Stensballe J., Wikkelsø A., et al. Fibrinogen concentrate for bleeding — a systematic review. Acta Anaesthesiol Scand. 2014; 58(9): 1061–74.
23. Galstyan G.M., Berkovskij A.L., Zhuravlev V.V., et al. Are fibrinogen preparations necessary in Russia? Anesteziologiya i reanimatologiya. 2014; 3: 49–59 (In Russian).
24. Rossaint R., Bouillon B., Cerny V., et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016; 20: 100.
25. Sultanbaev U.S., Ayupova R.F., Salihova A.K., Zhiburt E.B. On the adequacy of the quality control of cryoprecipitate. Transfuziologiya. 2016; 17(3): 41–6 (In Russian).
26. Gubanova M.N., Shihmirzaev T.A., Zhiburt E.B. Features of the national biological sample during blood transfusion. Menedzher zdravoohraneniya. 2016; 6: 53–9 (In Russian).
Review
For citations:
Zhiburt E.B., Chemodanov I.G., Shestakov E.A. CRYOPRECIPITATE PRODUCTION IN RUSSIA: PAST, PRESENT AND FUTURE. Russian journal of hematology and transfusiology. 2019;64(1):16-20. (In Russ.) https://doi.org/10.35754/0234-5730-2019-64-1-16-20
Views:
2979
Email this article 
